BRITTANY MENDO: Open Payments
NPI 1750055620 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 68 payments from 16 companies in 2025. Trend: 2023 $1,711 · 2024 $1,650 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $153 |
| Vanda Pharmaceuticals Inc. | 6 | $151 |
| Axsome Therapeutics, Inc. | 11 | $140 |
| Janssen Pharmaceuticals, Inc | 4 | $108 |
| Supernus Pharmaceuticals, Inc. | 4 | $59 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Lundbeck LLC | 3 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
Products named: VRAYLAR, CAPLYTA, Auvelity, FANAPT, INVEGA SUSTENNA, REXULTI, Qelbree, Jornay PM.
Industry payments across FL — which companies pay providers there.
